Global Alpha Emitters Market to Reach $5.2 Billion by 2027
Amid the COVID-19 crisis, the global market for Alpha Emitters estimated at US$672.3 Million in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at a CAGR of 34.1% over the analysis period 2020-2027. Melanoma, one of the segments analyzed in the report, is projected to record a 35.1% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Pancreatic Cancer segment is readjusted to a revised 37.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $202.5 Million, While China is Forecast to Grow at 33% CAGR
The Alpha Emitters market in the U.S. is estimated at US$202.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$885.2 Million by the year 2027 trailing a CAGR of 33% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 30.8% and 29.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 23.9% CAGR.
Ovarian Cancer Segment to Record 32.8% CAGR
In the global Ovarian Cancer segment, USA, Canada, Japan, China and Europe will drive the 32.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$112 Million in the year 2020 will reach a projected size of US$813.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$628.7 Million by the year 2027.
Select Competitors (Total 41 Featured):
Amid the COVID-19 crisis, the global market for Alpha Emitters estimated at US$672.3 Million in the year 2020, is projected to reach a revised size of US$5.2 Billion by 2027, growing at a CAGR of 34.1% over the analysis period 2020-2027. Melanoma, one of the segments analyzed in the report, is projected to record a 35.1% CAGR and reach US$1.1 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Pancreatic Cancer segment is readjusted to a revised 37.1% CAGR for the next 7-year period.
The U.S. Market is Estimated at $202.5 Million, While China is Forecast to Grow at 33% CAGR
The Alpha Emitters market in the U.S. is estimated at US$202.5 Million in the year 2020. China, the world's second largest economy, is forecast to reach a projected market size of US$885.2 Million by the year 2027 trailing a CAGR of 33% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 30.8% and 29.2% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 23.9% CAGR.
Ovarian Cancer Segment to Record 32.8% CAGR
In the global Ovarian Cancer segment, USA, Canada, Japan, China and Europe will drive the 32.8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$112 Million in the year 2020 will reach a projected size of US$813.7 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$628.7 Million by the year 2027.
Select Competitors (Total 41 Featured):
- Actinium Pharmaceuticals, Inc.
- Alpha Tau Medical
- Bayer AG
- Fusion Pharma
- IBA Group
- IBA Radiopharma Solutions
- Lantheus Medical Imaging, Inc.
- NTP Radiosotopes SOC Ltd.
- RadioMedix, Inc.
- Siemens Healthineers
- Telix Pharmaceuticals Ltd.
- Triad Isotopes, Inc.
Frequently Asked Questions about the Global Market for Alpha Emitters
What is the estimated value of the Global Market for Alpha Emitters?
What is the growth rate of the Global Market for Alpha Emitters?
What is the forecasted size of the Global Market for Alpha Emitters?
Note: Product cover images may vary from those shown
I. METHODOLOGY
II. EXECUTIVE SUMMARY
III. MARKET ANALYSIS
IV. COMPETITION
Note: Product cover images may vary from those shown
